Picture of genOway SA logo

ALGEN genOway SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for genOway SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Interim ReportInterim ReportARSARSARS
Standards:
FAS
FAS
FAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.572-1.04-0.687-0.3230.778
Depreciation
Non-Cash Items-0.431-0.375-0.122-0.347-0.183
Other Non-Cash Items
Changes in Working Capital0.997-2.11-0.739-1.99-0.975
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities2.16-2.19-0.164-0.5612.36
Capital Expenditures-3.86-1.14-4.52-2.28-1.92
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.1250.021-0.230.013-0.025
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-3.98-1.12-4.75-2.26-1.94
Financing Cash Flow Items-2.691.044.420
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.9291.356.545.71-1.14
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.891-1.971.632.89-0.727